Research identifies oncostatin M deficiency as a newly recognized inherited bone marrow failure syndrome that may predispose individuals to myeloid malignancies. This discovery could lead to further investigations into genetic testing and management strategies for affected patients.
oncostatin m deficiency a newly recognized inherited bone marrow failure syndrome with potential predisposition to myeloid malignancy
Original title: “Oncostatin M deficiency: A newly recognized inherited bone marrow failure syndrome with potential predisposition to myeloid malignancy.”